Vericel Corporation (VCEL)
Company Info
Highlights
$2.08B
$0.05
827.00
$238.54M
$173.03M
$10.55M
$37.39 - $63.00
$59.38
10.88%
7.72
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Vericel Corporation (VCEL) returned -24.80% year-to-date (YTD) and -14.29% over the past 12 months. Over the past 10 years, VCEL delivered an annualized return of 29.55%, outperforming the S&P 500 benchmark at 10.85%.
VCEL
-24.80%
8.61%
-28.97%
-14.29%
15.00%
23.49%
29.55%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of VCEL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 6.61% | -12.38% | -13.00% | -14.79% | 8.61% | -24.80% | |||||||
| 2024 | 20.70% | 6.28% | 13.88% | -11.82% | 3.99% | -3.82% | 10.11% | 2.24% | -18.20% | 4.24% | 32.02% | -5.56% | 54.20% |
| 2023 | 4.29% | 10.70% | -3.58% | 7.47% | 1.94% | 16.97% | -4.39% | -8.60% | 2.10% | 4.95% | 1.02% | 0.20% | 35.19% |
| 2022 | -9.47% | 15.82% | -7.26% | -25.43% | -4.74% | -7.26% | 29.23% | -23.33% | -7.01% | 15.86% | -15.07% | 15.37% | -32.98% |
| 2021 | 33.65% | 16.99% | 15.06% | 12.37% | -9.48% | -7.08% | 0.84% | 2.32% | -9.91% | -5.70% | -19.14% | 5.62% | 27.27% |
| 2020 | -5.75% | -5.85% | -40.61% | 58.12% | -0.83% | -3.89% | 19.32% | -3.88% | 16.91% | 0.00% | 37.83% | 20.91% | 77.47% |
| 2019 | -1.15% | 8.78% | -6.41% | -2.97% | -7.89% | 20.70% | 1.22% | -13.49% | -8.46% | 4.82% | 17.58% | -6.75% | 0.00% |
| 2018 | 41.28% | 3.90% | 24.37% | 34.17% | 0.75% | -27.88% | 7.73% | 16.75% | 15.98% | -21.20% | 57.67% | -1.02% | 219.27% |
| 2017 | -13.33% | 15.38% | -6.67% | -7.14% | 13.46% | 11.86% | -1.52% | 32.31% | 39.53% | -24.17% | -2.20% | 22.47% | 81.67% |
| 2016 | -18.22% | -4.27% | 190.10% | -50.85% | -2.78% | -19.64% | 0.44% | -0.88% | 25.00% | -21.43% | 9.09% | 25.00% | 16.28% |
| 2015 | 3.62% | 14.29% | 2.78% | -10.54% | -6.04% | 14.79% | -5.04% | -7.37% | -13.69% | -22.14% | 11.37% | 9.79% | -15.13% |
| 2014 | 11.76% | -6.65% | 30.27% | -9.79% | 27.53% | -18.81% | -22.93% | 22.47% | -26.36% | 3.86% | -5.41% | 8.57% | -5.88% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of VCEL is 33, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Vericel Corporation (VCEL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Vericel Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Vericel Corporation was 99.88%, occurring on Nov 17, 2015. The portfolio has not yet recovered.
The current Vericel Corporation drawdown is 97.07%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.88% | Sep 25, 1997 | 4567 | Nov 17, 2015 | — | — | — |
| -55.56% | Jun 24, 1997 | 45 | Aug 26, 1997 | 20 | Sep 24, 1997 | 65 |
| -51.67% | Mar 5, 1997 | 39 | May 1, 1997 | 36 | Jun 23, 1997 | 75 |
| -1.75% | Feb 10, 1997 | 13 | Feb 27, 1997 | 3 | Mar 4, 1997 | 16 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Vericel Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Vericel Corporation, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -50.0%.
Valuation
The Valuation section provides an overview of how Vericel Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for VCEL, comparing it with other companies in the Biotechnology industry. Currently, VCEL has a P/E ratio of 827.0. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for VCEL compared to other companies in the Biotechnology industry. VCEL currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for VCEL relative to other companies in the Biotechnology industry. Currently, VCEL has a P/S ratio of 8.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for VCEL in comparison with other companies in the Biotechnology industry. Currently, VCEL has a P/B value of 7.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |